What You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade Today [Yahoo! Finance]
BridgeBio Pharma, Inc. (BBIO)
Last bridgebio pharma, inc. earnings: 3/2 08:29 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
their statutory estimates that might leave shareholders a little shell-shocked. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative. Bidders are definitely seeing a different story, with the stock price of US$27.83 reflecting a 12% rise in the past week. With such a sharp increase, it seems brokers may have seen something that is not yet being priced in by the wider market. After the downgrade, the consensus from BridgeBio Pharma's twelve analysts is for revenues of US$125m in 2024, which would reflect a concerning 43% decline in sales compared to the last year of performance. Per-share losses are expected to see a sharp uptick, reaching US$3.30. However, before this estimates update, the consensus had been expecting revenues of US$137m and US$3.22 per share in losses. Overall it looks as though the analysts are negative in this update. Although sales forecasts held steady, the consensus also
Show less
Read more
Impact Snapshot
Event Time:
BBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BBIO alerts
High impacting BridgeBio Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
BBIO
News
- BridgeBio Pharma, Inc. (NASDAQ: BBIO) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.MarketBeat
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- BridgeBio Pharma, Inc. (NASDAQ: BBIO) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $50.00 price target on the stock.MarketBeat
- BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024 [Yahoo! Finance]Yahoo! Finance
- BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024GlobeNewswire
BBIO
Earnings
- 5/2/24 - Beat
BBIO
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/2/24 - Form 10-Q
- BBIO's page on the SEC website